Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 567-580

  Leri, Annarosa ^a   Liu, Yu ^a   Claudio, Pier Paolo ^b   Kajstura, Jan ^a   Wang, Xiaowei ^a   Wang, Shenglun ^a   Kang, Parminder ^a   Malhotra, Ashwani ^a,c   Anversa, Piero ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; RENIN; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; MUSCLE STRETCHING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TUMOR SUPPRESSOR GENE;

EID: 0032912721     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65302-3     Document Type: Article

References (46)

1. Rodriguez-Tarduchy G, Collins MKL, Garcia I, Lopez-Rivas A: Insulin-like growth factor 1 inhibits apoptosis in IL-3 dependent hemopoietic cells. J Immunol 1992, 149:535-540
2. D'Melo SR, Galli C, Ciotti T, Calissano P: Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 1993, 90:10989-10993
3. Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJ: Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor 1. Endocrinology 1994, 135:1845-1853
4. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997, 100:1991-1999
5. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nikolics K: A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992, 182:593-599
6. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM: Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995, 92:8031-8035
7. Sell C, Baserga R, Rubin R: Insulin-like growth factor (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res 1995, 55:303-306
8. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman H, Kajstura J, Rubin R, Zoltick P, Baserga R: The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res 1995, 55:2463-2469
9. Resnicoff M, Burgaud J-L, Rotman HL, Abraham D, Baserga R: Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor-1 receptor. Cancer Res 1995, 55:3739-3741
10. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 1996, 98:894-898
11. Cheng W, Li B, Kajstura J, Li P, Wo'in MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995, 96:2247-2259
12. Jung Y-K, Miura M, Yuan J: Suppression of interleukin-1β-converting enzyme-mediated cell death by insulin-like growth factor. J Biol Chem 1996, 271:5112-5117
13. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Kjaw B-A: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996, 335:1182-1189
14. Colucci WS: Apoptosis in the heart. N Engl J Med 1996, 335:1224-1226
15. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 1997, 336:1131-1141
16. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998, 101:1326-1342
17. Miyashita T, Reed J: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299
18. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994, 54:3131-3135
19. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P: p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997, 234:57-65
20. Baserga R, Resnicoff M, D'Ambrosio C, Valentinis B: The role of IGF-1 receptor in apoptosis. Vitam Horm 1997, 53:65-98
21. Milczarck GJ, Martinez J, Bowden GT: p53 phosphorylation: biochemical and functional consequences. Life Sci 1997, 60:1-11
22. Lohrum M, Scheidtmann KH: Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. Oncogene 1996, 12:2527-2539
23. Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299
24. Kubbutat MHG, Jones SN, Vousden KH: Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303
25. Momand J, Zambetti GP: Mdm-2: "Big Brother" of p53. J Cell Biochem 1997, 64:343-352
26. Lee AA, Delhaas T, Waldman LK, MacKenna DA, Villarreal FJ, McCulloch AD: An equibiaxial strain system for cultured cells. Am J Physiol 1996, 271:1400-1408
27. Hecker D, Page G, Lohrum M, Weiland S, Scheidtmann KH: Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene 1996, 12:953-961
28. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980, 47:1-9
29. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kastura J, Hintze TH, Anversa P: Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 1998, 97:194-203
30. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA: Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989, 67:657-670
31. Ko LJ, Prives C: p53: puzzle and paradigm Genes Dev 1996, 10: 1054-1072
32. Momand J, Zambetti GP: Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics. Oncogene 1996, 12:2273-2289
33. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Nature 1996, 274:948-953
34. Olson DC, Marechal V, Momand J, Cheng J, Romocki C, Levine AJ: Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 1993, 8:2353-2360
35. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975, 56:56-64
36. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984
37. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr: Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995, 95:619-627
38. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccà L: A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996, 334: 809-814
39. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Circulation 1990, 81:1161-1172
40. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992, 327:669-677
41. Iwai N, Shimoike H, Kinoshita M: Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 1995, 92:2690-2696
42. Wu X, Bayle JH, Olson D, Levine AJ: The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993, 7:1126-1132
43. Thut CJ, Goodrich JA, Tjian R: Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev 1997, 1986, 11:1974
44. Piette J, Neel H, Maréchal V: Mdm2: keeping p53 under control. Oncogene 1997, 15:1001-1010
45. Xiao Z-X, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR. Livingston DM: Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995, 375:694-698
46. Hupp TR, Lane DP: Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinase. Cold Spring Harbor Symp Quant Biol 1994, 59:195-206